These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2620472)

  • 1. Histopathology of severe renal vascular damage in blacks.
    Muirhead EE; Pitcock JA
    Clin Cardiol; 1989 Dec; 12(12 Suppl 4):IV58-65. PubMed ID: 2620472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hypertension due to musculo-mucoid intimal hyperplasia of intrarenal arteries. Absence of renal fibrinoid necrosis.
    Pitcock JA; Johnson JG; Share L; Hatch FE; Acchiardo SR; Black WD; Muirhead EE
    Circ Res; 1975 Jun; 36(6 Suppl 1):133-44. PubMed ID: 48431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hypertension in blacks. Malignant intrarenal arterial disease as observed by light and electron microscopy.
    Pitcock JA; Johnson JG; Hatch FE; Acchiardo S; Muirhead EE; Brown PS
    Hum Pathol; 1976 May; 7(3):333-46. PubMed ID: 1270065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.
    Fogo A; Breyer JA; Smith MC; Cleveland WH; Agodoa L; Kirk KA; Glassock R
    Kidney Int; 1997 Jan; 51(1):244-52. PubMed ID: 8995739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic proteinuria as a result of essential hypertension.
    Obialo CI; Hewan-Lowe K; Fulong B
    Kidney Blood Press Res; 2002; 25(4):250-4. PubMed ID: 12424428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race.
    Hughson MD; Puelles VG; Hoy WE; Douglas-Denton RN; Mott SA; Bertram JF
    Nephrol Dial Transplant; 2014 Jul; 29(7):1399-409. PubMed ID: 24327566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal histopathology of essential malignant hypertension in black South Africans.
    Isaacson C; Milne FJ; van Niekerk I; Kenyon MR; Mzamane DV
    S Afr Med J; 1991 Aug; 80(4):173-6. PubMed ID: 1876949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal proliferative arteriopathies and associated glomerular changes: a light and electron microscopic study.
    Sinclair RA; Antonovych TT; Mostofi FK
    Hum Pathol; 1976 Sep; 7(5):565-88. PubMed ID: 987010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal vascular lesions in severe hypertension. Transitional changes from benign to malignant nephrosclerosis.
    Akikusa B; Kondo Y; Irabu N; Shigematsu H
    Acta Pathol Jpn; 1983 Mar; 33(2):323-31. PubMed ID: 6869004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal parenchymal involvement in essential hypertension.
    Schwartz GL; Strong CG
    Med Clin North Am; 1987 Sep; 71(5):843-58. PubMed ID: 3306206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrosclerosis and hypertension.
    Ono H; Ono Y
    Med Clin North Am; 1997 Nov; 81(6):1273-88. PubMed ID: 9356598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis.
    Haruhara K; Tsuboi N; Kanzaki G; Koike K; Suyama M; Shimizu A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign nephrosclerosis: incidence, morphology and prognosis.
    Takebayashi S; Kiyoshi Y; Hisano S; Uesugi N; Sasatomi Y; Meng J; Sakata N
    Clin Nephrol; 2001 May; 55(5):349-56. PubMed ID: 11393379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glomerular mesangium in hypertension: a morphometrical comparison of nephrosclerosis with mesangioproliferative glomerulonephritis on renal biopsies.
    Hara M; Meyer D; Bohle A
    Virchows Arch A Pathol Anat Histol; 1975 Nov; 368(4):275-80. PubMed ID: 813366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertensive nephrosclerosis in African Americans versus Caucasians.
    Marcantoni C; Ma LJ; Federspiel C; Fogo AB
    Kidney Int; 2002 Jul; 62(1):172-80. PubMed ID: 12081576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
    Obialo CI; Hewan-Lowe K
    J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte loss in human hypertensive nephrosclerosis.
    Wang G; Lai FM; Kwan BC; Lai KB; Chow KM; Li PK; Szeto CC
    Am J Hypertens; 2009 Mar; 22(3):300-6. PubMed ID: 19131934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological analysis of malignant nephrosclerosis].
    Hoshi S; Yamaguchi Y; Sanaka T; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):488-98. PubMed ID: 18546880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decompensated benign nephrosclerosis and secondary malignant nephrosclerosis.
    Ratschek M; Ratschek E; Bohle A
    Clin Nephrol; 1986 May; 25(5):221-6. PubMed ID: 3720032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal pathology of essential hypertension.
    Sommers SC; Melamed J
    Am J Hypertens; 1990 Jul; 3(7):583-7. PubMed ID: 1694671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.